Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.4 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |